| Long name: |
ALDH1A1/ALDH1A2/ALDH1A3 Polyclonal Antibody |
| Antigen: |
ALDH1A1/ALDH1A2/ALDH1A3 |
| Synonim names: |
ALDH-E1, ALDH1, ALDH11, ALDH1A6, ALDH6, PUMB1, RALDH(II), RALDH1, RALDH2, RALDH2-T, RALDH3, ALDC |
| Gene name: |
ALDH1A1/ALDH1A2/ALDH1A3, ALDH1A1/ALDH1A2/ALDH1A3 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens) |
| Specificity: |
ALDH1A1/ALDH1A2/ALDH1A3, This is an antibody designed to detect ALDH1A1/ALDH1A2/ALDH1A3 |
| Purification method: |
This antibody was purified via antigen affinity purification method |
| Concentration: |
8mg/mL |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
EIA, ELI-Spot, IFA, Immunohistochemistry (IHC), Western Blot (WB), ELISA |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
ALDH1A1/ALDH1A2/ALDH1A3 |
| Short name: |
Anti- ALDH1A1/ALDH1A2/ALDH1A3 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
member A2/aldehyde dehydrogenase 1 family, member A3 (Antibody to), Antibody to ALDH1A1/aldehyde dehydrogenase 1 family |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ALDH1A2 and IDBG-13982 and ENSG00000128918 and 101928635, ALDH1A2 and IDBG-646601 and ENSBTAG00000010119 and 535075, ALDH1A3 and IDBG-32178 and ENSG00000184254 and 220, ALDH1A3 and IDBG-628582 and ENSBTAG00000009125 and 507093, ALDH1A6 and ALDH6 and MCOP8 and RALDH3, Aldh1a2 and IDBG-182855 and ENSMUSG00000013584 and 19378, Aldh1a3 and IDBG-191846 and ENSMUSG00000015134 and 56847, Cytoplasm, Cytoplasm, NAD or NADP as acceptor, NAD or NADP as acceptor, NAD or NADP as acceptor and also this GO :0016918 : retinal binding, NAD or NADP as acceptor and also this GO :0042803 : protein homodimerization activity and also this GO :0070324 : thyroid hormone binding and also this GO :0070403 : NAD+ binding, NAD or NADP as acceptor and molecular function this GO :0016918 and retinal binding and molecular function this GO :0021915 and neural tube development and biological process this GO :0021983 and pituitary gland development and biological process this GO :0030182 and neuron differentiation and biological process this GO :0030324 and lung development and biological process this GO :0030326 and embryonic limb morphogenesis and biological process this GO :0030900 and forebrain development and biological process this GO :0030902 and hindbrain development and biological process this GO :0031016 and pancreas development and biological process this GO :0031076 and embryonic camera-type eye development and biological process this GO :0032355 and response to estradiol and biological process this GO :0033189 and response to vitamin A and biological process this GO :0034097 and response to cytokine and biological process this GO :0035115 and embryonic forelimb morphogenesis and biological process this GO :0035799 and ureter maturation and biological process this GO :0042572 and retinol metabolic process and biological process this GO :0042573 and retinoic acid metabolic process and biological process this GO :0042574 and retinal metabolic process and biological process this GO :0042904 and 9-cis-retinoic acid biosynthetic process and biological process this GO :0043010 and camera-type eye development and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0048384 and retinoic acid receptor signaling pathway and biological process this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0048566 and embryonic digestive tract development and biological process this GO :0048738 and cardiac muscle tissue development and biological process this GO :0055114 and oxidation-reduction process and biological process this GO :0060324 and face development and biological process this GO :0071300 and cellular response to retinoic acid and biological process, NAD or NADP as acceptor and molecular function this GO :0021768 and nucleus accumbens development and biological process this GO :0031076 and embryonic camera-type eye development and biological process this GO :0042472 and inner ear morphogenesis and biological process this GO :0042572 and retinol metabolic process and biological process this GO :0042573 and retinoic acid metabolic process and biological process this GO :0042574 and retinal metabolic process and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0048048 and embryonic eye morphogenesis and biological process this GO :0050885 and neuromuscular process controlling balance and biological process this GO :0055114 and oxidation-reduction process and biological process this GO :0060013 and righting reflex and biological process this GO :0060166 and olfactory pit development and biological process this GO :0060324 and face development and biological process this GO :0070324 and thyroid hormone binding and molecular function this GO :0070403 and NAD+ binding and molecular function, RALDH(II) and RALDH2 and RALDH2-T, acting on the aldehyde or oxo group of donors, acting on the aldehyde or oxo group of donors, acting on the aldehyde or oxo group of donors, acting on the aldehyde or oxo group of donors, acting on the aldehyde or oxo group of donors, acting on the aldehyde or oxo group of donors, aldehyde dehydrogenase 1 family, member A2, member A3, oxidoreductase activity, oxidoreductase activity, this GO :0001568 and blood vessel development and biological process this GO :0001758 and retinal dehydrogenase activity and molecular function this GO :0001822 and kidney development and biological process this GO :0001889 and liver development and biological process this GO :0001936 and regulation of endothelial cell proliferation and biological process this GO :0002138 and retinoic acid biosynthetic process and biological process this GO :0003007 and heart morphogenesis and biological process this GO :0004028 and 3-chloroallyl aldehyde dehydrogenase activity and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0006776 and vitamin A metabolic process and biological process this GO :0007494 and midgut development and biological process this GO :0008152 and metabolic process and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008285 and negative regulation of cell proliferation and biological process this GO :0009855 and determination of bilateral symmetry and biological process this GO :0009952 and anterior/posterior pattern specification and biological process this GO :0009954 and proximal/distal pattern formation and biological process this GO :0010628 and positive regulation of gene expression and biological process this GO :0014032 and neural crest cell development and biological process this GO :0016331 and morphogenesis of embryonic epithelium and biological process this GO :0016491 and oxidoreductase activity and molecular function this GO :0016620 and oxidoreductase activity, this GO :0001758 : retinal dehydrogenase activity, this GO :0001758 : retinal dehydrogenase activity and also this GO :0004028 : 3-chloroallyl aldehyde dehydrogenase activity and also this GO :0016491 : oxidoreductase activity and also this GO :0016620 : oxidoreductase activity, this GO :0002072 and optic cup morphogenesis involved in camera-type eye development and biological process this GO :0002138 and retinoic acid biosynthetic process and biological process this GO :0004029 and aldehyde dehydrogenase (NAD) activity and molecular function this GO :0004030 and aldehyde dehydrogenase [NAD(P)+] activity and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0007626 and locomotory behavior and biological process this GO :0008152 and metabolic process and biological process this GO :0016491 and oxidoreductase activity and molecular function this GO :0016620 and oxidoreductase activity, this GO :0004028 : 3-chloroallyl aldehyde dehydrogenase activity, this GO :0004029 : aldehyde dehydrogenase (NAD) activity, this GO :0004029 : aldehyde dehydrogenase (NAD) activity and also this GO :0004030 : aldehyde dehydrogenase [NAD(P)+] activity and also this GO :0016491 : oxidoreductase activity and also this GO :0016620 : oxidoreductase activity, this GO :0004030 : aldehyde dehydrogenase [NAD(P)+] activity, this GO :0016491 : oxidoreductase activity, this GO :0016491 : oxidoreductase activity, this GO :0016620 : oxidoreductase activity, this GO :0016620 : oxidoreductase activity, this GO :0016918 : retinal binding, this GO :0042803 : protein homodimerization activity, this GO :0070324 : thyroid hormone binding, this GO :0070403 : NAD+ binding, 8854, 534200, aldehyde dehydrogenase 1 family |
| Identity: |
409 |
| Gene: |
ALDH1A3 |
More about : ALDH1A3 |
| Long gene name: |
aldehyde dehydrogenase 1 family member A3 |
| Synonyms gene: |
ALDH6 |
| Synonyms gene name: |
aldehyde dehydrogenase 1 family, member A3 |
| Synonyms: |
RALDH3 |
| Synonyms name: |
retinaldehyde dehydrogenase 3 |
| Locus: |
15q26, 3 |
| Discovery year: |
1994-07-07 |
| GenBank acession: |
U07919 |
| Entrez gene record: |
220 |
| Pubmed identfication: |
7698756 |
| Classification: |
Aldehyde dehydrogenases |
| Havana BLAST/BLAT: |
OTTHUMG00000186439 |